Menu

Kamel BOUMALI

Durham

En résumé

A keyword to keep in mind to qualify my professional path is diversity:
-diversity in terms of sales experience: B to C and B to B.
-diversity in terms of size of organizations where I've been working in: big, middle-size and small-size organizations.
-diversity in terms of typology of organizations where I've been employed: big pharma, professional patent search firm, Contrat Commercial Organization (CCO) and Contract Research Organization (CRO).
-diversity in terms of areas of expertise/drug development phases which I have been focused on: Drug delivery, Intellectual Property, vitro-animal free approaches, vivo preclinical, clinical translational research, Phase I-Phase IIa clinical phases.
-diversity in terms of therapeutic areas which I have been involved with: Analgesic, Gastroenterology, Cardiology, Pneumology, Vaccines, Biosimilars, Oncology, Skin, Hematology, Endocrinology.
-diversity in terms of targeted industries/clients which I have been focused on: General Physicians/Cardiologists, generic developers, Pharmas, Biotech’s, Cosmetic industry, technology transfer offices, academic groups.
-diversity in terms of assigned sales territories which I have been responsible for: Europe, Middle-East, North America, South Asia.
-diversity of geographical locations where I've been settled in for the purpose of my professional activities: Paris area, London area, Dijon, Home-office based.

Core-activities:
-In-depth expertise of various health industries (pharma, biotech, generics, personal care).
-Identification of potential clients using advanced marketing tools (social media, emailing, webinar, the implementation of strategic partnerships, and the participation to specific customer-organized events.
-Conversion of prospects into leads based on the assessment of specific needs and the implementation of a thorough qualification process.
-Attendance to weekly scientific review to examine along with internal experts RFPs before moving ahead into a business proposal.
-Generation of new and repeat business respectively from new clients acquisition and already established accounts by securing a robust sales pipeline.
-In charge of achieving monthly, quarterly, annual sales forecasts and follow-up of the progression versus the implemented marketing and business action plan.
-Project Management capabilities and working cross-functionally with R&D, clinical, marketing, legal, quality assurance, purchasing departments.
-Verbal and written reporting on the ongoing projects status to sales and top management (CEO, COO) on a regular basis.
-Building and driving of high-level relationships with existing and new customers and providing them with product support and training.
-Introduction of strong initiatives as a part of team and value-added service by revising customer approaches and sales methodologies (SPIN Selling,..).
*Instrumental in training new sales persons during cluster internal meetings.

Core-competencies:
-Top performing;
-Strong critical thinking and analytical skills, Praised for my superior verbal and written communication skills, Real project management capabilities;
-Excellent creative problem-solving skills, Ability to handle tight deadlines and Capable of working on multiples activities at any one time;
-Proactive and proven leadership capabilities with ability to motivate others;
-Very good organizational skills;
-Outgoing personality with Excellent team work and Customer Oriented;

Mes compétences :
Biotechnologies
Business
Business development
Drug development
Gestion de projets
Gestion de projets marketing
Industrie pharmaceutique
International
Marketing
Marketing International
Patent

Entreprises

  • Quintiles - Associate BD Director

    Durham 2017 - maintenant Quintiles-IMS is a leading integrated information and technology healthcare service provider worldwide dedicated to helping improve its clients through clinical scientific and commercial results.

    Further to the fusion of Quintiles and IMS, the joined company is about 50 000 people conducting operations in more than 100 countries.

    Quintiles-IMS is a leader in Phase I studies for 5 consecutive years.

    The Early Clinical Development (ECD) of your molecule is critical to the success of getting your drug to market. Start your clinical program on the right path to confidently conduct your phase I trial.

    At Quintiles-IMS, our dedicated and highly staff puts you, volunteers and patients first helping your study proceed with speed, quality, safety, flexibility to meet your phase I changing needs.
  • Innovenn - Senior Business Development Manager

    2016 - 2017 Innovenn was established in May 2013 as a subsidiary of Venn Life Sciences, a European Contract Research Organization providing clinical trial management solutions.

    Working with organizations from the cosmetic, personal care, pharmaceutical and medical device sectors, Innovenn is a dynamic go to market hub, providing a unique portfolio of products and a limited range of services at the forefront of reconstructed in vitro skin technologies.

    Innovenn' skin science division actually offers the supply of advanced 3D full-thickness living human skin equivalents to your facilities to help you discover, develop and evaluate performing innovative skin care products and ingredients.
  • Oncodesign - Business Account Manager

    Dijon 2009 - 2016 Founded in 1 995 and headed by Dr. Philippe Genne, Oncodesign® is a Dijon based CRO and employs more than 100 people, including 1 5 PhD graduates.

    The organization is expert in the preclinical assessment of anti-cancer therapy and is leading 3 main technological modules:

    • Chi-Mice® focuses on the development of in vivo chimeric experimental models (patient derived
    models, humanized mice, new disease relevant models).

    • PharmImage® is dedicated to non-invasive, multi-modal pharmaco-imaging (optical imaging,
    SPECT, MRI , PET; pre-clinical and Phase 0 imaging biomarkers).

    • PREDICT® specializes in conventional in vitro and in vivo pharmacology (ADMET, toxicology,
    combinations, PK/PD, xenograft, syngeneic models, proof of concept).

  • GenericsWeb Europe - European Business Development Manager

    2007 - 2008 Established in 1999, GenericsWeb is a professional patent search firm with a customer base including legal practices, government departments, consultants and generic manufacturers.

    GenericsWeb Pipeline Patent Intelligence provides the most comprehensive, relevant and accurate patent information to help generic industry find business opportunities in key territories where generic versions of drugs coming off patents could be properly launched.
  • Novartis - Medical Sales Representative

    RUEIL MALMAISON 2004 - 2006 The Primary Care Division intends to lead the way in developing treatments for a huge area of unmet medical needs within the cardio-metabolic landscape.

    Primary responsibilities include :
    - To drive sales performance by building and executing sales plans to meet targeted expectations for assigned territory.
    - To build-up effective professional relationships with key customers to support the delivery of business results
    - To establish Novartis as a leader in cardiovascular diseases.
  • Winner - Medical Sales Representative

    2002 - 2004 *Winner is a global CCO designed to help pharmaceutical players support the marketing promotion of their drugs portfolio towards medical professionals by providing additional sales force.

    *Active promotion of Astrazeneca products in Gastroenterology, Pneumology and Cardiology areas from October 2002 to September 2003.

    *Active promotion of Wyeth Consumer Health products like Antitussives, Vitamins, Analgesic, Calcium from September 2003 to March 2004.
  • Ethypharm - Business Development Project Manager

    SaintCloud 2001 - 2001 -Ethypharm' expertise extends from the phase of conception up to the marketing of the pharmaceutical product, including its registration and production.
     
    -Originally specializing in dosage forms and Drug Delivery Systems (DDS), Ethypharm has gained unique expertise in the formulation, development, registration and production of drugs with complex dosage forms.
     
    -Ethypharm performs drug repositionning (Life Cycle Management) using existing molecules, either to enhance their use or address new treatment needs.

Formations

  • Ecole Supérieure De Commerce Dijon Bourgogne

    Dijon 2000 - 2001 Master's program in Management of Pharmaceutical Industry

    *Writing of a professional thesis dealing with clients focused project management.

    *Marketing knowledge including forecast product sales, life cycle product management, implementation of Marketing plan, SWOT analysis, identification and development of new market opportunities.

    *Praised by Pierre Le Sourd, ex president of BMS for my verbal communication dealing with Evolution of the pharmaceutica
  • Université Nancy 1 Henri Poincaré

    Vandoeuvre Les Nancy 1998 - 1999 Post Graduate Degree in Biology Engineering

    The objective of the Research work has been to incorporate nifedipine-containing sustained released forms of acrylic nanoparticles harboring different physicochemical properties into solid dosage forms like tablets.
  • Université Nancy 1 Henri Poincaré

    Vandoeuvre Les Nancy 1997 - 1998 Maitrise de Biologie Cellulaire et Physiologie Animale
  • Université Nancy 1 Henri Poincaré

    Vandoeuvre Les Nancy 1996 - 1997 Licence Biologie Cellulaire et Physiologie

Réseau

Annuaire des membres :